GlassScriptPhysician profile
Alaa Gabi
NPI 1114281524
$28,886.88
in general payments reported to CMS, 2019-2025
40 companies · $7,194 in 2025
The $7,194 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,631 · 2020: $1,198 · 2021: $1,433 · 2022: $5,693 · 2023: $1,446 · 2024: $4,292 · 2025: $7,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,956 · Travel and Lodging: $5,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,955.72 |
| Travel and Lodging | $5,975.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,891.75 | 2021-2025 | Advisa Dr Mri Surescan, Azure Xt Dr Mri Surescan, Micra |
| Boston Scientific Corporation | $4,440.79 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Medtronic Vascular, INC. | $2,433.89 | 2019-2020 | |
| Abbott Laboratories | $2,061.21 | 2019-2025 | Aveir, Mitraclip |
| Edwards Lifesciences Corporation | $1,545.31 | 2019-2023 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $888.54 | 2019-2024 | Farxiga, Brilinta |
| Amgen INC. | $886.53 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $791.04 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $655.31 | 2022-2025 | Impella |
| Cardiovascular Systems INC. | $592.21 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $497.25 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $476.08 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $436.65 | 2020-2025 | Lifevest |
| Novo Nordisk INC | $277.35 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $222.63 | 2019-2024 | Camzyos, Eliquis |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $214.53 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $187.59 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $166.62 | 2021-2025 | Verquvo |
| Amarin Pharma, INC. | $124.21 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $111.08 | 2025 | Opsynvi, Opsumit, Uptravi |
| Inari Medical, INC. | $102.83 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $99.61 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.46 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $82.41 | 2020-2024 | Nexletol |
| Chiesi USA, INC. | $78.54 | 2020-2021 | |
| Biosense Webster, INC. | $76.62 | 2020-2025 | Carto 3 |
| Angiodynamics, INC. | $67.40 | 2022 | |
| Getinge USA Sales, LLC | $50.85 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $48.29 | 2022-2023 | Gore Cardioform Septal Occluder |
| Cordis US Corp. | $41.80 | 2023 | Rain Sheath Transradial, Zephyr |
| Veryan Medical Incorporated | $41.39 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $31.93 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $31.38 | 2024 | |
| Terumo Medical Corporation | $27.47 | 2019 | |
| Atricure, INC. | $25.70 | 2023 | |
| Philips North America LLC | $25.68 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Zoll Circulation INC | $22.29 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| United Therapeutics Corporation | $15.18 | 2024 | Tyvaso |
| Teleflex LLC | $15.18 | 2022 | |
| Intact Vascular, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alaa Gabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.